Related Experiment Video
Updated: Apr 29, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica
Francesco Muratore1, Giulia Pazzola, Nicolò Pipitone
1Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy. muratore.francesco@asmn.re.it.
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are related conditions. Large-vessel involvement (LVI) is increasingly found in GCA, potentially causing serious complications, while rare in PMR.
Area of Science:
- Rheumatology
- Vascular Medicine
- Internal Medicine
Background:
- Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory conditions affecting older adults.
- Large-vessel involvement (LVI) is increasingly recognized in GCA, with potential for severe vascular complications.
- Vascular complications are rare in PMR, but overlap between GCA and PMR is common.
Purpose of the Study:
- To review current understanding of large-vessel involvement (LVI) in GCA and PMR.
- To address controversies in the diagnosis, monitoring, and management of LVI in these conditions.
- To highlight the clinical significance of LVI in GCA versus PMR.
Main Methods:
- Literature review of recent studies on LVI in GCA and PMR.
- Analysis of diagnostic modalities for LVI.
- Discussion of management strategies for vascular complications.
Main Results:
- LVI is increasingly detected in GCA using advanced imaging, leading to complications like aortic aneurysms and dissections.
- Limb artery stenosis is a recognized complication of LVI in GCA.
- Vascular complications directly attributed to PMR are exceedingly rare.
Conclusions:
- LVI is a significant concern in GCA, necessitating careful diagnosis and management.
- The role and management of LVI in PMR require further clarification.
- Distinguishing LVI in GCA from PMR is crucial for appropriate patient care.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Hypersensitivity Reactions: Immune-Complex Reactions
Myasthenia Gravis ll: Pathophysiology
Chronic Inflammation: Introduction

